Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $17.3 million.

  • Amicus Therapeutics' Change in Acquisitions & Divestments fell 5635.81% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.3 million, marking a year-over-year decrease of 5745.81%. This contributed to the annual value of $117.8 million for FY2024, which is 4028.25% down from last year.
  • As of Q3 2025, Amicus Therapeutics' Change in Acquisitions & Divestments stood at $17.3 million, which was down 5635.81% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Change in Acquisitions & Divestments registered a high of $163.7 million during Q1 2021, and its lowest value of $6.2 million during Q1 2025.
  • Over the past 5 years, Amicus Therapeutics' median Change in Acquisitions & Divestments value was $54.9 million (recorded in 2023), while the average stood at $58.4 million.
  • In the last 5 years, Amicus Therapeutics' Change in Acquisitions & Divestments surged by 5421.14% in 2021 and then tumbled by 8416.48% in 2025.
  • Quarter analysis of 5 years shows Amicus Therapeutics' Change in Acquisitions & Divestments stood at $81.7 million in 2021, then fell by 6.97% to $76.0 million in 2022, then tumbled by 78.42% to $16.4 million in 2023, then dropped by 3.02% to $15.9 million in 2024, then increased by 8.5% to $17.3 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $17.3 million for Q3 2025, versus $11.0 million for Q2 2025 and $6.2 million for Q1 2025.